| Drug Name | Nexviazyme (Avalglucosidase alfa) |
|---|---|
| Drug Class | |
| Risk minimization type |
Healthcare provider guide
|
| Specialty (Theraputic area) | |
| Risk |
Guidance for health care professionals on risks associated with alglucosidase alfa administration, clinical risk management and immunology testing
|
| Health care provider guide |
|